UCB has appointed Mark McDade, executive vice president, global operations.

Marty Cearnal joined Cumberland Pharmaceuticals, a Nashville, TN firm, as SVP commercial development.

Eisai has announced several promotions and hires.

Aegerion Pharmaceuticals, a specialty manufacturer focused on cardiovascular and metabolic disease, has appointed Peter Garrambone, Jr., to the company's board of directors.

Halozyme Therapeutics, a biopharma specializing in products targeting the extracellular matrix, has appointed Patrick O'Connor, vice president, research, Michael LaBarre, vice president, product development, and James Cartoni, vice president, legal.

Synergy Pharmaceuticals, a biopharma focused on gastrointestinal disorders and diseases, has appointed Melvin Spigelman to its board of directors.

Prometheus Laboratories announced the appointment of Mark Spring as SVP and chief financial officer.

Concentric Pharma Advertising hired Tim O'Grady as VP group account supervisor.

GSW Worldwide named Thomas Groves EVP, director of strategic planning.

GlaxoSmithKline has hired former FDA chief counsel and First Amendment specialist Dan Troy as its new general counsel.